NorthRock Partners, LLC - PETROS PHARMACEUTICALS INC ownership

PETROS PHARMACEUTICALS INC's ticker is PTPI and the CUSIP is 71678J100. A total of 25 filers reported holding PETROS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NorthRock Partners, LLC ownership history of PETROS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$431,000
-37.2%
115,295
-47.4%
0.04%
-38.6%
Q2 2021$686,000
-45.5%
219,188
-35.1%
0.06%
-50.4%
Q1 2021$1,259,000
-25.7%
337,531
-12.3%
0.12%
-31.1%
Q4 2020$1,694,000385,0310.17%
Other shareholders
PETROS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
EMFO, LLC 10,000$5,0000.01%
Newbridge Financial Services Group, Inc. 1,200$1,0000.00%
OSAIC HOLDINGS, INC. 1,135$1,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 76,654$39,0000.00%
BlackRock Inc. 165,095$84,0000.00%
J. Goldman & Co LP 31,250$00.00%
Citadel Advisors 15,000$8,0000.00%
Citadel Advisors 163,600$83,0000.00%
Citadel Advisors 87,320$45,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 28,500$15,0000.00%
View complete list of PETROS PHARMACEUTICALS INC shareholders